hospital-acquired pneumonia

Thought Leader Select Assists Global Biopharma in Battle Against Gram Negative Bacteria

In a recent Thought Leader Select Blog article, we detailed an engagement with a leading global biopharmaceutical company in its efforts to develop treatments for a variety of infections ranging from hospital-acquired pneumonia to urinary tract infections. As part of the strategic engagement with Thought Leader Select, the company has asked us to help them …

Thought Leader Select Assists Global Biopharma in Battle Against Gram Negative Bacteria Read More »

Biopharma Leader Chooses Thought Leader Select for KOL Initiatives in Bacterial Infections

September 26, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader recently tabbed North Carolina’s Thought Leader Select to assist the company with an upcoming slate of key opinion leader (KOL) initiatives in the area of bacterial infections. The KOL initiatives will support a developing portfolio of intravenous treatments for certain bacterial infections. Thought Leader Select, headquartered in Chapel …

Biopharma Leader Chooses Thought Leader Select for KOL Initiatives in Bacterial Infections Read More »